{
  "success": true,
  "enriched": 33,
  "total_entities": 1458,
  "by_type": {
    "StudyArm": 2,
    "EligibilityCriterion": 4,
    "Objective": 12,
    "Endpoint": 15
  },
  "enriched_items": [
    {
      "type": "StudyArm",
      "name": "Arm A: Avelumab + Axitinib",
      "arm_type": "Experimental Arm",
      "nci_code": "C174266"
    },
    {
      "type": "StudyArm",
      "name": "Arm B: Sunitinib",
      "arm_type": "Active Comparator Arm",
      "nci_code": "C174267"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Advanced Renal Cell Carcinoma",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "First-line Treatment",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "ECOG Performance Status",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Prior Systemic Therapy Exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "Objective",
      "name": "Primary Efficacy Objective",
      "level": "Trial Primary Objective",
      "nci_code": "C85826"
    },
    {
      "type": "Objective",
      "name": "Secondary PFS Objective (Unselected)",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary OS Objective (Unselected)",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Other Efficacy Measures",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Next-line Therapy Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Safety Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Toxicity Discontinuation Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Toxicity Proportion Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Pharmacokinetics Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Biomarker Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Immunogenicity Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Patient-Reported Outcomes Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Endpoint",
      "name": "Primary PFS (PD-L1+)",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Primary OS (PD-L1+)",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Secondary PFS (Unselected)",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Secondary OS (Unselected)",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Tumor Response Endpoints",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Investigator PFS",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "PFS2 Endpoint",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Safety Endpoints",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Time to Discontinuation",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Treatment Discontinuation",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "PK Parameters",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Biomarker Status",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Biomarker Subgroup Outcomes",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Immunogenicity Endpoint",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "PRO Endpoints",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    }
  ],
  "cache_stats": {
    "total_entries": 50,
    "fresh_entries": 38,
    "stale_entries": 12,
    "cache_file": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\core\\evs_cache\\nci_codes.json"
  }
}